CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy (CANDIDATE)
研究概览
详细说明
The investigators produce customized gene target panel by selecting genes that are commonly found in colorectal cancer and metastasis from existing literature.
In patients diagnosed with lung metastases from colorectal cancer, 20mL of whole blood is collected before and after local treatment (surgery or radiation) and cell-free DNA (cfDNA) is extracted from the collected blood. Thereafter, 20 mL of whole blood is additionally collected once after 3 months (±2 months) and once after 6 months (±2 months) during follow-up and cfDNA is extracted. The investigators perform sequencing from the extracted cfDNA.
The investigators compare the mutations detected in cfDNA before and after local treatment and identify the trend of reducing mutations in cfDNA after local treatment. So The investigators discover biomarkers for the outcome of local treatment. The investigators also search for mutations for target drugs from mutation profiling of cfDNA.
研究类型
注册 (预期的)
联系人和位置
学习联系方式
- 姓名:Seung-Tae Lee
- 电话号码:82-2-2228-2446
- 邮箱:LEE.ST@yuhs.ac
学习地点
-
-
-
Seoul、大韩民国
- Department of Laboratory Medicine, Yonsei University College of Medicine
-
接触:
- Seung-Tae Lee
- 电话号码:82-2-2228-2446
- 邮箱:LEE.ST@yuhs.ac
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- adults over 19 years of age
- those who understand research and have written consent
- cases diagnosed with lung metastases from colorectal cancer
Exclusion Criteria:
- pregnant women, nursing women
- those who lack the ability to voluntarily agree
- participation in other clinical trials where drugs for clinical trials are administered within the past four weeks as of the date of participation in clinical trials
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Lung metastases from colorectal cancer, local ablative therapy (surgery or radiation)
patients diagnosed with lung metastases from colorectal cancer and undergoing surgery or radiation for lumg metastasis
|
detection of tumor DNA alteration in cf-DNA
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
correlation between circulating tumor DNA (ctDNA) before and after local treatment (surgery or radiation) and recurrence of lung metastases from colorectal cancer
大体时间:about 6 month but additional extension for patients with relapse after local treatment
|
The investigations investigate whether ctDNA changes and f/u ctDNA fraction after local treatment (surgery or radiation) can be useful as markers to predict the outcome of local treatments.
|
about 6 month but additional extension for patients with relapse after local treatment
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
mutations related to target drug
大体时间:about 6 month but additional extension for patients with relapse after local treatment
|
The investigations check for target drug related mutations from mutation profiling of ctDNA.
|
about 6 month but additional extension for patients with relapse after local treatment
|
合作者和调查者
调查人员
- 首席研究员:Seung-Tae Lee、Severance Hospital
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.